Global AIDS Update 2018
Closing Gaps
Breaking Barriers
Righting injustices
Glob Health Sci Pract February 1, 2014 vol. 2 no. 1 p. 103-116
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Health Systems in Transition. Vol. 5 No.3 2015
Глобальными приоритетами для лечения туберкулеза (ТБ) и борьбы с ним являются улучшенное и ранее выявление случаев туберкулеза, в том числе случаев заболевания с о...трицательным мазком мокроты, которые часто ассоциируются с вирусом иммунодефицита человека (ВИЧ) и ранним возрастом, а также расширенные возможности для диагностики туберкулеза с множественной лекарственной устойчивостью (МЛУ-ТБ)
more
Analyse des politiques et des programmes : opportunités et défis pour l’UNFPAseptembre
J Nepal Health Res Counc 2012 May;10(21):82-87
Tuberculosis cases, TB deaths
Briefing Note no. 80 November 2015
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has... become
a global priority in public health due to its widespread consequences and increasing occurrence from
time to time. AMR has a formidable impact where the existing antibiotics and other antimicrobial
medicines become ineffective, and infections become increasingly difficult or impossible to treat.
more
This report explores the extent to which evidence, policy, normative guidance and commitments on HIV and gender-based violence, and their interlinkages, is being translated into action on the ground in fragile settings. These issues are explored through the lens of training of peace support operatio...ns deploying African troops across Africa and beyond.
more